Bottom line
Is JDOC a good fund? The bottom line
JDOC is an actively managed health care sector ETF from J.P. Morgan.
Its expense ratio is 0.65% — about $65 a year on every $10,000 invested, cheaper than 74% of health care sector funds we track.
It returned +14.9% over one year (as of Dec 31, 2025, per its prospectus).
With $9.1 million in net assets and 61 holdings, its largest position is AbbVie, Inc. (7.8%) and the top 10 make up 48.1% of the portfolio.
The closest lower-cost alternative we found is XLV (0.08%, 62% top-holdings overlap).
What to watch
- Small fund ($9.1 million) — small funds are likelier to close
Updated Nov 19, 2026
What JDOC invests in
The Fund seeks to provide long-term capital appreciation.
The Fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies (Healthcare Companies) which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. The Fund will invest in common stocks of Healthcare Companies across all market capitalizations, but expects to invest a majority of its assets in mid- and large- capitalization companies. The Fund will invest globally, including in both developed and emerging market countries, although it expects to invest a majority of its Assets in Healthcare Companies located in the U.S. Prior to June 1, 2026, under normal circumstances, the Fund invests at least 80% of its Assets in the equity securities of Healthcare Companies. The adviser…
From the fund's prospectus (filed Apr 30, 2026).
JDOC performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| JDOC | +14.9% | — | — |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2025
What JDOC costs
On a $10,000 investment, JDOC's 0.65% expense ratio costs about $65 a year. The prospectus estimates $810 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
JDOC top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | AbbVie, Inc. | 7.85% |
| 2 | Eli Lilly & Co. | 7.76% |
| 3 | UnitedHealth Group, Inc. | 5.85% |
| 4 | Merck & Co., Inc. | 4.82% |
| 5 | Johnson & Johnson | 4.82% |
| 6 | AstraZeneca plc | 3.76% |
| 7 | Thermo Fisher Scientific, Inc. | 3.73% |
| 8 | Bristol-Myers Squibb Co. | 3.57% |
| 9 | Abbott Laboratories | 3.11% |
| 10 | CVS Health Corp. | 2.83% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 48.1% of the fund. See all top 25 holdings and asset mix →
Alternatives to JDOC
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| SPDR (State Street) | XLV State Street(R) Health Care Select… | 0.08% | 62% | Compare |
| Fidelity | FHLC Fidelity MSCI Health Care Index ETF | 0.084% | 63% | Compare |
| Vanguard | VGHCX Vanguard Health Care Fund | 0.33% | 62% | Compare |
| iShares | IXJ iShares Global Healthcare ETF | 0.38% | 68% | Compare |
| Schwab | SWHFX Schwab Health Care Fund | 0.8% | 57% | Compare |
| T. Rowe Price | PRHSX T. Rowe Price Health Sciences Fund, Inc. | 0.83% | 58% | Compare |